Pioneer Pharma (Hong Kong) Co Ltd is 10% Owner at NovaBay Pharmaceuticals, Inc. (NBY). They have made 2 open-market trades across 1 company since 2013, most recently 2019-06-11.
CIK 0001593301
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5.7M since 2013, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NBY | 5,188,421 | $10.1M |
Shares reported on the most recent Form 4, priced at the 2019-06-13 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.